Streetbeat News

Products Services

ALIM

The UK's National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance recommending ILUVIEN for chronic diabetic macular edema (DME) in patients with a natural lens. Alimera Sciences, Inc. (NASDAQ:ALIM), the producer of ILUVIEN, views this as a significant step forward, potentially benefiting up to 75% of the DME population in the UK. Final Guidance will be published after February 22, 2024, and NHS England and Wales have committed to funding the treatment shortly after publication.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 1:01 pm

NSP

WDAY

Workday and Insperity have entered into an exclusive strategic partnership to jointly develop, brand, market, and sell a leading full-service HR solution targeted at small and midsize businesses. This collaboration aims to leverage both companies' strengths to offer a comprehensive HR package that addresses the unique needs of this segment.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:59 pm

SYRE

Spyre Therapeutics, Inc. (NASDAQ:SYRE), a biotech company focusing on Inflammatory Bowel Disease (IBD) treatments, announced that three abstracts regarding its lead product candidates, SPY001 and SPY002, will be presented at the 19th Annual Congress of the European Crohn's and Colitis Organization (ECCO) in Stockholm, Sweden. These presentations will highlight preclinical findings and the potential for extended dosing intervals. Phase 1 clinical studies for both candidates are expected to begin this year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:34 pm

GM

General Motors (GM) has hired a leading expert in next-generation battery technology to spearhead its battery development efforts, aiming to enhance its position in the electric vehicle (EV) market. This strategic move underscores GM's commitment to innovation and its ambition to be a frontrunner in the EV industry.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:33 pm

FHTX

LLY

Foghorn Therapeutics' stock price increased following Eli Lilly's decision to select FHD-909 for clinical development, initially targeting lung cancer.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:22 pm

PLUG

Plug Power announced that its Plug Cryogenic Trailers have departed from the Tennessee Hydrogen Production Plant for customer deliveries, marking a significant step in the company's logistics and delivery capabilities for hydrogen fuel.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:16 pm

BABA

During Alibaba Group Holding Ltd's (NYSE:BABA) Q4 2023 earnings call, CEO Eddie Wu emphasized the potential for AI-driven synergies between Alibaba Cloud and the Taobao and Tmall Group (TTG), focusing on enhancing search conversion and ad monetization. Despite a 5% Y/Y revenue growth to $36.67 billion, Alibaba's earnings slightly missed consensus estimates. The revenue growth across different units varied, with the International Digital Commerce Group seeing a 44% increase.

Portfolio Pulse from Ananya Gairola

February 08, 2024 | 12:14 pm

FHTX

LLY

Foghorn announced that Eli Lilly has selected FHD-909 for clinical development targeting BRG1 mutated non-small cell lung cancer (NSCLC). Lilly plans to file an Investigational New Drug application in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:13 pm

AKTS

Akoustis Technologies has announced its patented XBAW filters are being incorporated into two new programs with an enterprise Wi-Fi access point solutions provider. This collaboration highlights the growing adoption of Akoustis's advanced filter technology in the enterprise Wi-Fi market.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:13 pm

PLTR

Palantir Technologies (PLTR) and Bapco Upstream have entered into a strategic, multi-year partnership. This collaboration aims to deploy Palantir's software to enhance and expedite Bapco Upstream's capabilities in powering the next generation of energy in the Kingdom of Bahrain.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:11 pm